IPG Investment Advisors’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

IPG Investment Advisors’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-61,500	Closed	-$205K	–	150
2019 Q4	$205K	Buy	+61,500	New	+$196K	0.06%	122
2019 Q2	–	Sell	-61,500	Closed	-$231K	–	173
2019 Q1	$231K	Buy	+61,500	New	+$230K	0.08%	126
2018 Q1	–	Sell	-61,500	Closed	-$370K	–	178
2017 Q4	$370K	Buy	+61,500	New	+$370K	0.15%	87
2017 Q3	–	Sell	-14,575	Closed	-$67.6K	–	165
2017 Q2	$67.6K	Buy	+14,575	New	+$65K	0.03%	132

IPG Investment Advisors's FOMX Position: Q1 2020 in Review

IPG Investment Advisors sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 61,500 shares — an estimated $205K sold.

IPG Investment Advisors first reported a position in FOMX in Q2 2017 and held it in 4 quarters. The position peaked at $370K in Q4 2017. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

IPG Investment Advisors reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
IPG Investment Advisors sold 61,500 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $205K.
IPG Investment Advisors first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2017 and held it in 4 quarters.
IPG Investment Advisors's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $370K in Q4 2017.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on IPG Investment Advisors's 13F filing for Q1 2020, filed 12 May 2020.